THERMO FISHER SCIENTIFIC INC. (TMO) FY2025 Q1 P&L / Income Statement

2025-01-01 to 2025-03-29

Swipe to see the full flow
THERMO FISHER SCIENTIFIC INC. (TMO) FY2025 Q1 P&L / Income StatementIncome statement for 2025-01-01 through 2025-03-29. View: Business segment (15 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUE RECONCILIATIONREVENUEGROSSOPERATINGPRE-TAXNETClinical researchResearch and safety market channelPharma servicesBiosciencesChromatography and mass spectrometryGenetic sciencesBioProductionElectron microscopyLaboratory productsHealthcare market channelChemical analysisClinical diagnosticsImmunoDiagnosticsMicrobiologyTransplant diagnosticsTotal revenuesRevenue before reconciliation (calculated)Components above reported revenue (calculated)Gross profit (calculated)Cost of revenue (calculated)Cost of revenuesOperating incomeOperating expenses (calculated)Income before income taxesOther income (expense), net (calculated)Net incomeBenefit from/(provision for) income taxesEquity in earnings/(losses) of unconsolidated entitiesRevenue before reconciliation (calculated)Revenue beforereconciliation(calculated)$11.13 BGross profit (calculated)Gross profit(calculated)$4.24 BTotal revenuesTotal revenues$10.36 BOperating incomeOperating income$1.72 BIncome before income taxesPretax income$1.62 BNet incomeNet income$1.51 BClinical researchClinical research$1.94 BOperating expenses (calculated)Operating expenses(calculated)$2.52 BResearch and safety market channelResearch and safetymarket channel$1.73 BBenefit from/(provision for) income taxesBenefitfrom/(provisionfor) income taxes$95.00 MCost of revenue (calculated)Cost of revenue(calculated)$6.13 BOther income (expense), net (calculated)Other income,net (calculated)−$96.00 MPharma servicesPharma services$1.61 BEquity in earnings/(losses) of unconsolidated entitiesEquity inearnings/(losses)of unconsolidated…−$14.00 MBiosciencesBiosciences$993.00 MChromatography and mass spectrometryChromatography andmass spectrometry$773.00 MCost of revenuesCost ofrevenues$6.13 BGenetic sciencesGenetic sciences$677.00 MComponents above reported revenue (calculated)Components abovereported revenue(calculated)−$769.00 MBioProductionBioProduction$671.00 MElectron microscopyElectron microscopy$659.00 MLaboratory productsLaboratory products$582.00 MHealthcare market channelHealthcaremarket channel$474.00 MChemical analysisChemical analysis$286.00 MClinical diagnosticsClinical diagnostics$263.00 MImmunoDiagnosticsImmunoDiagnostics$217.00 MMicrobiologyMicrobiology$152.00 MTransplant diagnosticsTransplant diagnostics$113.00 M
Chart details

THERMO FISHER SCIENTIFIC INC. (TMO) FY2025 Q1 P&L / Income Statement

Income statement for 2025-01-01 through 2025-03-29. View: Business segment (15 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues
10,364,000,000 US dollars
Cost of revenue (calculated)
6,129,000,000 US dollars
Gross profit (calculated)
4,235,000,000 US dollars
Operating expenses (calculated)
2,519,000,000 US dollars
Operating income
1,716,000,000 US dollars
Other income (expense), net (calculated)
negative 96,000,000 US dollars
Income before income taxes
1,620,000,000 US dollars
Benefit from/(provision for) income taxes
95,000,000 US dollars
Net income
1,511,000,000 US dollars
Chromatography and mass spectrometry
773,000,000 US dollars
Chemical analysis
286,000,000 US dollars
Electron microscopy
659,000,000 US dollars
Laboratory products
582,000,000 US dollars
Research and safety market channel
1,727,000,000 US dollars
Pharma services
1,607,000,000 US dollars
Clinical research
1,939,000,000 US dollars
Biosciences
993,000,000 US dollars
Genetic sciences
677,000,000 US dollars
BioProduction
671,000,000 US dollars
Clinical diagnostics
263,000,000 US dollars
ImmunoDiagnostics
217,000,000 US dollars
Microbiology
152,000,000 US dollars
Transplant diagnostics
113,000,000 US dollars
Healthcare market channel
474,000,000 US dollars
Cost of revenues
6,129,000,000 US dollars
Selling, general and administrative expenses
2,078,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Research and development expenses
342,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Restructuring and other costs
98,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Revenue before reconciliation (calculated)
11,133,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
Components above reported revenue (calculated)
negative 769,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item.
Equity in earnings/(losses) of unconsolidated entities
negative 14,000,000 US dollars. Reported below-tax contribution to net income.

Chart connections

  • Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
  • Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
  • Of which attributable to THERMO FISHER SCIENTIFIC INC.: $1.51 B; to noncontrolling interests: $4.00 M.
THERMO FISHER SCIENTIFIC INC. (TMO) FY2025 Q1 Revenue by Business Segment (15 categories) Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Gross margin

40.9%

Gross profit / revenue

Operating margin

16.6%

Operating profit / revenue

Cash conversion

47.8%

Operating cash / net income, same period

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!